<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Clinical Pharmacology News</title> 
<link>http://www.mdlinx.com/RheumatologyLinx/news.cfm/newspage/1/spec_id/18/subspec_id/362</link> 
<description>Clinical Pharmacology</description> 
<language>en-us</language> 
<copyright>Copyright 2010 MDLinx, Inc.</copyright>










 



<item> 
<title><![CDATA[Indirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs]]></title> 
<link>http://www.mdlinx.com/RheumatologyLinx/xml-article.cfm/3081545</link> 
<pubDate>3/16/2010</pubDate> 
<description><![CDATA[<b>Seminars in Arthritis and Rheumatism</b>]]></description> 
<guid>http://www.mdlinx.com/RheumatologyLinx/xml-article.cfm/3081545</guid>
</item> 
 

<item> 
<title><![CDATA[Prolonged Remission of Chronic Reactive Arthritis Treated With Three Infusions of Infliximab]]></title> 
<link>http://www.mdlinx.com/RheumatologyLinx/xml-article.cfm/3073745</link> 
<pubDate>3/16/2010</pubDate> 
<description><![CDATA[<b>Journal of Clinical Rheumatology (JCR)</b>]]></description> 
<guid>http://www.mdlinx.com/RheumatologyLinx/xml-article.cfm/3073745</guid>
</item> 


 

<item> 
<title><![CDATA[Psoriatic Arthritis and its Novel Therapeutics]]></title> 
<link>http://www.mdlinx.com/RheumatologyLinx/xml-article.cfm/3067960</link> 
<pubDate>3/16/2010</pubDate> 
<description><![CDATA[<b>Current Rheumatology Reviews</b>]]></description> 
<guid>http://www.mdlinx.com/RheumatologyLinx/xml-article.cfm/3067960</guid>
</item> 
 
 


  


</channel> 
</rss>

